Carmen Spetter
Investment Manager
Get their honest, personalized take on your startup.
Sign in to pitch Carmen →At a glance
- Full Name
- Carmen Spetter
- Title
- Director
- Firm
- Rivean Capital (formerly Gilde Buy Out Partners)
- Firm Type
- Private Equity — mid-market buyout (not an angel/seed investor; the original stub classification appears incorrect)
- Investment Stage
- Buyout, growth equity, public-to-private, spin-off and succession transactions in established mid-market companies
- Check Size
- Firm targets companies with enterprise values of roughly €75 million–€600 million (with at least ~€8 million of cash flow); Rivean manages funds well in excess of €5 billion (Fund VII ~€1.6bn)
- Target Company Profile
- Established, profitable medium-sized European businesses
- Sector Focus
- Logistics, chemicals/industrial, business services, food & beverage, information technology, consumer services
- Geographic Focus
- Core European markets — DACH (Germany/Austria/Switzerland), Benelux, and Italy
- Location
- Netherlands (Rivean's Dutch / Amsterdam office)
Background
Carmen Spetter is a Director at Rivean Capital, the pan-European mid-market private equity firm that operated as Gilde Buy Out Partners until it rebranded to Rivean Capital in February 2022. She joined the firm's Dutch office in June 2017 and progressed through the investment ranks — Associate (2017), Senior Associate (2018) and Investment Manager (2019–2020) — before reaching Director. The "[hidden]" address in the stub data reflects the firm's former Gilde branding; her current address is at riveancapital.com.
Before joining Gilde/Rivean, Carmen worked in Bank of America Merrill Lynch's Corporate Finance / M&A team, based in London. Earlier in her career she gained advisory and internship experience in financial advisory at Lazard and NIBC, and in legal advisory at Dutch law firm De Brauw Blackstone Westbroek.
Academically, she holds two master's degrees from Dutch universities: a Master's in Corporate Law from the Vrije Universiteit Amsterdam and a Master's in Financial Economics from Erasmus University Rotterdam — a legal-plus-financial background well suited to structuring buyout transactions.
Note: Rivean Capital is distinct from Gilde Healthcare (a separate healthcare-focused venture/growth and PE investor that also carries the historic "Gilde" name). Carmen sits with the buyout/private-equity business, Rivean Capital.
Investment Thesis & Focus
- Control-oriented mid-market buyouts, not seed/angel checks — Rivean acquires established, profitable European businesses rather than early-stage startups.
- Company size: enterprise values roughly €75m–€600m, with meaningful cash flow (≈€8m+).
- Sectors: logistics, chemicals and industrials, business services, food & beverage, IT, and consumer services.
- Geography: DACH, Benelux and Italy as core markets, backed by €5bn+ of managed funds.
- Deal types: buyouts, growth equity, carve-outs/divestitures, public-to-private, spin-offs and succession/founder transitions — often partnering with management teams for accelerated growth.
Notable Investments
- TenCate Protective Fabrics — global developer and manufacturer of high-performance protective fabrics for garment makers; owned by Rivean together with Parcom and Capital A Investment Partners.
- Enstall — international provider of rooftop solar mounting/racking systems.
- KINKELDER — Netherlands-based manufacturer of industrial circular saw blades (HSS and carbide-tipped).
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.